← The library
Research only

Melanotan-2

aka MT-2, MT2

Melanocortin receptor agonist (skin pigmentation, libido)

Peptide·Facts·ReferenceMT-2Melanocortin receptor agonist (…Lot · ref/MELANO · 2026·05
The vial
M2
The molecule

Half-life

~33 minutes (short — vs MT-1 at 33 hours)

How long it stays active in your body

Dosing

Daily during loading (1–2 weeks), then weekly

How often you take a dose

Route

SubQ

How it goes into the body

Status

Research

Sold for lab research — not approved for humans

Education only. Many compounds discussed are research chemicals not approved for human use in the US. This is not medical advice — consult a licensed physician.

What it is

A synthetic analog of α-MSH that activates multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R). MC1R activation drives melanin production (tanning); MC4R activation drives libido (similar mechanism to PT-141). Not FDA-approved. Real expert disagreement on whether it belongs in any stack.

How it works

Non-selective melanocortin receptor agonist. MC1R → melanocyte stimulation → darker pigmentation + UV protection. MC4R → central libido enhancement. Crosses the blood-brain barrier readily — also affects appetite, mood, and erection pathways.

What the research says

Originally developed at University of Arizona for melanoma prevention. Limited human trials. Most use is recreational tanning + libido enhancement via gray-market sources. The non-selective receptor activation is the source of side-effect concerns.

Sources: PubMed: Melanotan II

Common dosing ranges

Range
250–500 mcg/day loading; 0.5–1 mg/week maintenance
Frequency
Daily during loading (1–2 weeks), then weekly
Duration
Cycle until desired tan, then maintain

Sources: PubMed

Administration

SubQ

Side effects

Common

  • Nausea (often debilitating, especially early)
  • Facial flushing
  • Spontaneous erections
  • Loss of appetite
  • Darkening of existing moles and freckles

Serious / theoretical

  • New mole formation — Dr. Jones DC reports moles taking months to disappear after cessation
  • Theoretical melanoma risk (unstudied)
  • Cardiovascular effects from sustained MC receptor activation

Sources: PubMed: MT-II safety

Notes

Real expert split: JD Denham + Jones DC warn against (new mole formation, short half-life); Dr. Tatem rates it S-tier (now prescription-available); Bachmeyer flags non-selective receptor activation. MT-1 (33-hour half-life) is the cleaner alternative if pigmentation is the goal. For libido alone, PT-141 is the more targeted choice.